相关实验视频

Updated: Jul 9, 2025

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

清细胞细胞癌中的抗原标

Nicholas R Schindler^1,2, David A Braun^1,2

¹Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.

Kidney cancer (Clifton, Va.)

|November 28, 2023

概括

识别抗原对于改善晚期细胞癌 (RCC) 免疫检查点抑制剂 (ICI) 疗法至关重要. 这项研究探讨了潜在的抗原,以提高RCC患者的治疗疗效和安全性.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
遗传学是一个遗传学.

背景情况:

免疫检查点抑制剂 (ICI) 已推进了晚期细胞癌 (RCC) 治疗.
然而,许多患者无法获得长期益处,有些人经历了不良影响.
由于RCC的突变负担很小,新抗原负载与ICI反应之间没有相关性,因此需要进一步调查.

研究的目的:

在RCC中识别有效的抗瘤免疫的向抗原.
提高RCC免疫疗法的疗效和安全性.
探索抗原导向治疗清晰细胞RCC的方法.

主要方法:

在RCC中对潜在向抗原类的审查.
分析之前和正在进行的抗原调查工作.
专注于清晰的细胞组织学.

主要成果:

大多数患有晚期RCC的患者无法从目前的ICI中获益.
抗原鉴定对于理解ICI反应和耐药性至关重要.
向特定抗原可能会改善免疫治疗结果.

结论:

对于RCC,需要进行协同的抗原发现工作.
了解目标抗原将改善反应和耐药性的知识.
这项工作为RCC精确抗原定向免疫治疗奠定了基础.

关键词:

细胞癌是细胞癌.T细胞受体受体的 T 细胞受体.癌症疫苗癌症疫苗癌症疫苗仿真抗原受体T细胞的T细胞受体新抗原是一种新抗原.瘤抗原是一种瘤抗原.

更多相关视频

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.